Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Pharmacology & Therapeutics
|
September 29, 2000
Basis for effective combination cancer chemotherapy with antimetabolites
G J Peters, C L van der Wilt, C J van Moorsel, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines
C J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
British Journal of Cancer
|
June 12, 2003
Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines
A M Bergman, H M Pinedo, I Talianidis, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
M van Nuland, S L Groenland, A M Bergman, et al.
Biochemical Pharmacology
|
March 24, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines
A M Bergman, C M Kuiper, D A Voorn, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Mechanisms of synergism between gemcitabine and cisplatin
C J van Moorsel, G Veerman, J B Vermorken, et al.
Biochemical Pharmacology
|
May 2, 2001
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
A M Bergman, B Munch-Petersen, P B Jensen, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits
K Smid, A M Bergman, P P Eijk, et al.
Biochemical Pharmacology
|
February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase
A M Bergman, H M Pinedo, A P Jongsma, et al.
Biochimica Et Biophysica Acta
|
March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
C J van Moorsel, A M Bergman, G Veerman, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Pharmacology & Therapeutics
|
September 29, 2000
Basis for effective combination cancer chemotherapy with antimetabolites
G J Peters, C L van der Wilt, C J van Moorsel, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Differential effects of gemcitabine on nucleotide pools of 19 solid tumor cell lines
C J van Moorsel, G Veerman, V W Ruiz van Haperen, et al.
British Journal of Cancer
|
June 12, 2003
Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines
A M Bergman, H M Pinedo, I Talianidis, et al.
Prostate Cancer and Prostatic Diseases
|
October 16, 2019
Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
M van Nuland, S L Groenland, A M Bergman, et al.
Biochemical Pharmacology
|
March 24, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines
A M Bergman, C M Kuiper, D A Voorn, et al.
Advances in Experimental Medicine and Biology
|
May 23, 1998
Mechanisms of synergism between gemcitabine and cisplatin
C J van Moorsel, G Veerman, J B Vermorken, et al.
Biochemical Pharmacology
|
May 2, 2001
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
A M Bergman, B Munch-Petersen, P B Jensen, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 27, 2006
Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits
K Smid, A M Bergman, P P Eijk, et al.
Biochemical Pharmacology
|
February 5, 1999
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase
A M Bergman, H M Pinedo, A P Jongsma, et al.
Biochimica Et Biophysica Acta
|
March 4, 2000
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
C J van Moorsel, A M Bergman, G Veerman, et al.
Page
of 5